• Mineralys Therapeutics Chief Medical Officer Rodman David Malcom exercised stock options for 2,170 shares at USD 16 on Aug. 10.
• He sold 2,170 shares the same day at USD 27.09.
• Directly held common stock fell to 51,384 shares following the transactions.
• Directly held stock options declined to 13,024 following the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001933414-26-000118), on August 12, 2026, and is solely responsible for the information contained therein.